COMMUNIQUÉS West-GlobeNewswire
-
Claus Frisenberg Pedersen, CFO in Oncology Venture buys shares in Oncology Venture and MPI
27/03/2018 - 17:21 -
EZBIS Partners with ABILITY Network to Help Chiropractic Providers Simplify Revenue Cycle Management
27/03/2018 - 16:00 -
Metabolon and DIAN Open New Metabolomics Laboratory in China
27/03/2018 - 15:57 -
HIFU for Prostate Cancer Now Available at Baptist Health Louisville in Kentucky
27/03/2018 - 15:30 -
Wildflower’s California Acquisition Moves Forward After Completion of Due Diligence
27/03/2018 - 15:18 -
PotNetwork Holding Inc. Releases First Corporate Video Highlighting Its Success in the CBD Oil Industry
27/03/2018 - 15:16 -
Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance
27/03/2018 - 15:08 -
Survey: People Turning to Online Mental Health Resources as Stigma Runs Rampant Among Workplaces, Schools, Communities
27/03/2018 - 15:03 -
Medecision Launches Aerial CarePlanner 360™, the Latest Release in Suite of Advanced Care Management Solutions
27/03/2018 - 15:00 -
Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
27/03/2018 - 15:00 -
BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds
27/03/2018 - 14:30 -
Agritek Holdings, Inc. Comments On Passage Of U.S. Consolidated Appropriations Act Of 2018 Retaining State Medical Marijuana Protections As Company Increases Equity Stakes In Colorado and Puerto Rico Cultivation Operations
27/03/2018 - 14:30 -
Golden Leaf Holdings Signs Letter of Intent with BlackShire Capital to Launch Chalice Farms Franchise Model
27/03/2018 - 14:30 -
Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
27/03/2018 - 14:30 -
Summit Therapeutics Announces the Results of Placing and Issue of Equity
27/03/2018 - 14:09 -
AveXis Gene Therapy Awarded SAKIGAKE Designation for Spinal Muscular Atrophy Type 1
27/03/2018 - 14:05 -
Karmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non-Hodgkin Lymphoma
27/03/2018 - 14:05 -
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection
27/03/2018 - 14:00 -
Krystal Submits Investigational New Drug (IND) Application for KB103, Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa
27/03/2018 - 14:00
Pages